Hospital-Based Treatment for Opioid Use Disorder

N/A

Recruiting

Led By Susan L Calcaterra, MD

Research Sponsored by University of Colorado, Denver

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up calculate mean monthly cows scores over a three year time frame (including pre and post implementation) to assess for change

Awards & highlights

No Placebo-Only Group

Summary

"This trial introduced a new treatment program for opioid use disorder in 12 hospitals in Colorado to help adults with opioid use disorder who are hospitalized."

Who is the study for?

This trial is for hospitalized adults in Colorado who are diagnosed with Opioid Use Disorder (OUD) and are experiencing a gap in treatment. Specific eligibility criteria details were not provided, so it's important to contact the study organizers for more information.

What is being tested?

The trial is testing an intervention designed to improve OUD treatment among hospitalized patients across 12 hospitals. It aims to address the current shortcomings in care for individuals suffering from opioid addiction.

What are the potential side effects?

Since specific interventions and their side effects aren't detailed, potential participants should ask the research team about what treatments are involved and any associated risks or side effects.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ calculate monthly prescribing rates over a three year time frame (including pre and post implementation) to assess for change

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~calculate monthly prescribing rates over a three year time frame (including pre and post implementation) to assess for change

This trial's timeline: 3 weeks for screening, Varies for treatment, and calculate monthly prescribing rates over a three year time frame (including pre and post implementation) to assess for change for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in buprenorphine prescribing at hospital discharge

Secondary study objectives

Change in rates of methadone prescribing during hospitalization

Other study objectives

Change in average (mean) COWS score over time

Change in naloxone prescribing at hospital discharge

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: OUD interventionExperimental Treatment1 Intervention

Participants received education on the diagnosis and management of OUD, have access to protocols to walk them through assessment of OUD using Diagnostic and Statistical Manual, fifth Edition (DSM)-5, COWS score to calculate severity of opioid withdrawal, buprenorphine or methadone initiation with pre-populated orders, and clickable links for OUD treatment referral post discharge.

Do I qualify?Apply below to find out